We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Medlab Middle East Looks to The Future of Laboratories

By LabMedica International staff writers
Posted on 24 Jan 2025
Print article
Image: The 24th edition of Medlab Middle East will be held from 3-6 February at the Dubai World Trade Centre (Photo courtesy of Informa Markets)
Image: The 24th edition of Medlab Middle East will be held from 3-6 February at the Dubai World Trade Centre (Photo courtesy of Informa Markets)

The medical laboratory market in the Middle East and Africa (MEA) is expected to experience substantial growth, with projections indicating it could reach USD 473.84 million by 2029, growing at a strong Compound Annual Growth Rate (CAGR) of 12.6%. Against this promising backdrop, Medlab Middle East (Dubai, UAE), organized by Informa Markets (London, UK), will take place from February 3-6, 2024, in Dubai, UAE. This event will gather medical laboratory professionals and industry leaders to discuss the future of laboratories and their transformative impact on healthcare both regionally and globally. The 2025 edition of Medlab Middle East will focus on the theme "Empowering today’s medical labs for tomorrow’s global future." Key product categories showcased will include disposable products, medical equipment, IT, pharma/nutrition, and lab services. Medlab Middle East 2024 generated an impressive USD 670 million in business, reinforcing its significance in the global healthcare sector.

Medical laboratories play a vital role in the healthcare system, providing diagnostic and testing services that are critical for disease identification, monitoring, and treatment decisions. With an increasing prevalence of chronic and non-communicable diseases, a growing population, and mandatory healthcare and insurance coverage in the MEA region, the demand for medical laboratory services has surged. Technologies in medical labs enhance the ability to collect and analyze patient health data, leading to more accurate, personalized diagnoses and treatment, ultimately improving patient outcomes, reducing costs, and increasing accessibility.

Recent technological advances have significantly improved healthcare, with key innovations including Next-Generation Sequencing (NGS), Point-of-Care Testing (POCT), and 3D Printing. Artificial Intelligence (AI) and machine learning are also making their mark in medical lab technology, enabling data analytics and predictive algorithms to improve diagnoses and patient care. At Medlab Middle East, global laboratory leaders such as Abbott, Beckman Coulter, Randox, and Sansure will showcase their latest innovations. Sansure will present the IPonatic III Pro, a POCT solution that utilizes magnetic extraction technology to overcome the limitations of traditional PCR methods and offer fast, reliable results.

Beckman Coulter will display the DxC 500 AU Chemistry Analyzer to optimize lab operations and the Dxl 9000 Access Immunoassay Analyzer to meet increased diagnostic demand. Randox will unveil the Acusera Smart Range, which simplifies stock management, reduces inventory, and saves time for laboratories. The Medlab Middle East Congress will feature over 150 world-class speakers and offer 12 CME-accredited conference tracks covering topics like Lab Management, Clinical Chemistry, Hematology, Clinical Microbiology, Molecular Diagnostics, and more. New this year, Thought Leadership Forums will focus on Women’s Health and Precision Medicine. The Global Lab Leaders Breakfast Forum, set for days two and three of the event, will bring together experts and stakeholders to drive advancements in laboratory practices globally.

“Now in its 24th edition, Medlab Middle East showcases the forefront of laboratory technology and innovation, attracting global leaders, pioneers, and industry experts,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare. “The event offers a premier platform for experiencing groundbreaking discoveries, exploring cutting-edge solutions, and engaging in invaluable networking opportunities.”

Related Links:
Medlab Middle East
Informa Markets

New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centrifuge
Hematocrit Centrifuge 7511M4
New
Coagulation Analyzer
CS-2400

Print article

Channels

Clinical Chemistry

view channel
Image: The research team has developed the uCR-Chip device to enhance kidney function testing (Photo courtesy of University of Manitoba)

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.